Cancer Incidence and Mortality for Lewis County, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 172.4 499.9 466.1-535.5 89.0 523.8 475.2-576.3 83.4 483.3 436.1-534.5 63.2 180.2 160.5-201.9 33.4 203.8 173.6-238.0 29.8 160.9 135.2-190.4
Oral cavity and pharynx 4.4 13.7 8.4-21.2 3.4 21.2 11.9-34.9 1.0 6.3 2.0-15.4 1.0 2.7 0.9-6.8 0.8 4.6 1.2-12.7 0.2 0.8 0.0-6.7
Esophagus 1.2 3.2 1.2-7.5 1.2 6.9 2.5-15.9 0.0 0.0 0.0-5.7 1.0 3.6 1.1-8.6 0.8 5.2 1.4-13.7 0.2 2.1 0.1-10.2
Stomach 1.8 5.5 2.5-10.9 1.4 8.1 3.2-17.4 0.4 2.9 0.3-11.1 1.0 2.8 0.9-7.0 0.6 3.6 0.7-11.2 0.4 2.1 0.2-9.0
Colorectal 18.0 56.0 44.6-69.4 8.8 55.2 39.8-74.8 9.2 57.5 41.3-78.0 7.6 23.8 16.7-33.1 3.6 24.6 14.4-39.3 4.0 22.1 13.1-35.4
Colon excluding rectum 13.2 40.3 30.9-51.8 6.0 38.0 25.4-55.0 7.2 42.5 29.2-60.0 7.0 22.2 15.3-31.3 3.4 23.3 13.4-37.8 3.6 20.5 11.8-33.6
Rectum & rectosigmoid 4.8 15.6 9.8-23.7 2.8 17.2 9.3-29.4 2.0 15.0 6.9-28.1 0.6 1.6 0.3-5.3 0.2 1.3 0.0-7.8 0.4 1.6 0.2-7.8
Liver / intrahepatic bile duct 1.6 4.6 2.0-9.4 1.2 6.7 2.4-15.3 0.4 2.5 0.3-9.6 1.2 3.6 1.3-8.2 0.8 4.8 1.3-13.1 0.4 2.3 0.3-9.3
Pancreas 4.6 12.7 8.0-19.4 1.6 8.7 3.7-18.0 3.0 15.2 8.4-26.0 5.0 14.0 9.0-21.0 2.0 11.7 5.5-22.2 3.0 15.3 8.4-26.3
Larynx 1.0 3.3 1.0-8.1 0.6 3.5 0.7-11.0 0.4 3.2 0.3-11.6 0.6 1.9 0.3-6.1 0.4 1.8 0.2-8.1 0.2 2.1 0.1-10.2
Lung and bronchus 19.8 56.0 45.4-68.6 13.2 78.2 60.2-100.2 6.6 36.4 24.9-52.0 16.0 45.1 35.7-56.5 9.0 54.4 39.5-73.5 7.0 37.5 25.9-53.1
Melanoma of the skin 8.6 26.3 18.8-35.9 4.0 24.5 14.8-38.6 4.6 28.8 17.7-44.4 1.6 4.6 1.9-9.4 1.0 6.6 2.1-15.8 0.6 2.7 0.6-9.4
Female breast             22.8 130.2 106.7-157.7             4.0 21.4 12.8-34.1
Cervix uteri             0.8 5.3 1.4-14.1             0.2 1.7 0.0-9.0
Corpus uterus and NOS             5.8 33.7 21.9-49.7             1.0 5.8 1.8-14.5
Ovary             2.8 15.0 8.2-26.0             1.2 6.3 2.3-14.7
Prostate       21.0 114.2 93.0-139.2             3.4 20.2 11.7-33.0      
Testis       1.2 9.9 3.5-21.6             0.0 0.0 0.0-5.6      
Urinary bladder (incl. in situ) 9.2 25.0 18.2-33.8 7.4 43.2 30.2-60.4 1.8 9.3 4.2-18.6 2.2 6.5 3.2-11.9 1.6 10.6 4.6-21.2 0.6 2.7 0.5-9.4
Kidney and renal pelvis 6.2 18.4 12.3-26.5 3.8 22.6 13.5-35.9 2.4 14.0 6.9-25.5 1.6 4.4 1.9-9.0 1.2 7.0 2.5-15.9 0.4 1.6 0.2-7.8
Brain and other central nervous system 2.4 7.5 3.8-13.6 1.0 5.1 1.6-12.9 1.4 9.8 3.7-20.7 2.0 5.2 2.5-9.9 0.8 4.2 1.1-11.7 1.2 5.9 2.1-14.0
Thyroid 3.8 13.5 7.9-21.4 1.4 9.2 3.5-19.8 2.4 17.9 9.0-31.7 0.0 0.0 0.0-2.8 0.0 0.0 0.0-5.6 0.0 0.0 0.0-5.7
Hodgkin lymphoma 0.2 0.5 0.0-3.4 0.0 0.0 0.0-5.6 0.2 0.9 0.0-7.0 0.0 0.0 0.0-2.8 0.0 0.0 0.0-5.6 0.0 0.0 0.0-5.7
Non-Hodgkin lymphomas 8.4 22.3 16.0-30.6 4.8 27.0 17.2-41.0 3.6 17.3 10.2-28.4 2.8 7.2 3.9-12.5 1.2 6.2 2.2-14.6 1.6 7.6 3.2-16.2
Myeloma 2.0 6.1 2.9-11.4 1.0 6.8 2.2-16.1 1.0 5.7 1.8-14.2 0.8 2.2 0.6-6.1 0.8 4.6 1.2-12.6 0.0 0.0 0.0-5.7
Leukemias 6.6 19.4 13.2-27.7 3.2 19.7 11.1-32.6 3.4 20.0 11.4-33.1 3.0 8.9 4.9-15.0 1.6 10.6 4.6-21.2 1.4 8.4 3.2-18.2

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.